Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammed Shiraz Moosa

Showing results (1-10 of 5) with videos related to

Pageof 1
Sort By:
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2020
Reply to AuthorMuhammed Shiraz Moosa, Gary Maartens, Karen Cohen
Southern African Journal of HIV Medicine|August 4, 2022
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohortMuhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, et al.
British Journal of Clinical Pharmacology|January 13, 2023
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injuryMuhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver InjuryMuhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, et al.
Trials|May 9, 2024
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trialPhiona E Namale, Linda Boloko, Marcia Vermeulen, et al.
Pageof 1

Showing results (1-10 of 5) with videos related to

Sort By:
Pageof 1
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2020
Reply to AuthorMuhammed Shiraz Moosa, Gary Maartens, Karen Cohen
Southern African Journal of HIV Medicine|August 4, 2022
Rechallenge after anti-tuberculosis drug-induced liver injury in a high HIV prevalence cohortMuhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, et al.
British Journal of Clinical Pharmacology|January 13, 2023
Analysis of serum microRNA-122 in a randomized controlled trial of N-acetylcysteine for treatment of antituberculosis drug-induced liver injuryMuhammed Shiraz Moosa, Giusy Russomanno, Jeffrey R Dorfman, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|August 27, 2020
A Randomized Controlled Trial of Intravenous N-Acetylcysteine in the Management of Anti-tuberculosis Drug-Induced Liver InjuryMuhammed Shiraz Moosa, Gary Maartens, Hannah Gunter, et al.
Trials|May 9, 2024
Testing novel strategies for patients hospitalised with HIV-associated disseminated tuberculosis (NewStrat-TB): protocol for a randomised controlled trialPhiona E Namale, Linda Boloko, Marcia Vermeulen, et al.
Pageof 1